453
Views
8
CrossRef citations to date
0
Altmetric
Perspective

Electroconvulsive therapy for post-traumatic stress disorder: efficacy, mechanisms and a hypothesis for new directions

, &
Pages 749-753 | Received 27 Feb 2016, Accepted 08 Apr 2016, Published online: 03 May 2016

References

  • Rodriguez P, Holowka DW, Marx BP. Assessment of posttraumatic stress disorder-related functional impairment: a review. J Rehabil Res Dev. 2012;49:649–665.
  • Brady KT, Killeen TK, Brewerton T, et al. Comorbidity of psychiatric disorders and posttraumatic stress disorder. J Clin Psychiatry. 2000;61(Suppl 7):22–32.
  • Pietrzak RH, Goldstein RB, Southwick SM, et al. Medical comorbidity of full and partial posttraumatic stress disorder in US adults: results from wave 2 of the national epidemiologic survey on alcohol and related conditions. Psychosom Med. 2011;73:697–707.
  • Pompili M, Sher L, Serafini G, et al. Posttraumatic stress disorder and suicide risk among veterans: a literature review. J Nerv Ment Dis. 2013;201:802–812.
  • Helsley S, Sheikh T, Kim KY, et al. ECT therapy in PTSD. Am J Psychiatry. 1999;156:494–495.
  • Hanretta AT, Malek-Ahmadi P. Combined use of ECT with duloxetine and olanzapine: a case report. J ECT. 2006;22:139–141.
  • Watts BV. Electroconvulsive therapy for comorbid major depressive disorder and posttraumatic stress disorder. J ECT. 2007;23:93–95.
  • Watts BV, Groft A. Retrospective evaluation of the dexamethasone suppression test as a predictor of response to electroconvulsive therapy in patients with comorbid major depressive disorder and posttraumatic stress disorder. J ECT. 2010;26:213–217.
  • Andrade C, Mushtaq D, Margoob MA. Electroconvulsive therapy for posttraumatic stress disorder: the importance of assessment measures. J ECT. 2011;27:341.
  • Ahmadi N, Moss L, Simon E, et al. Efficacy and long-term clinical outcome of comorbid posttraumatic stress disorder and major depressive disorder after electroconvulsive therapy. Depress Anxiety. 2015 Nov 10. doi:10.1002/da.22451. Epub ahead of print.
  • Margoob MA, Ali Z, Andrade C. Efficacy of ECT in chronic, severe, antidepressant- and CBT-refractory PTSD: an open, prospective study. Brain Stimul. 2010;3:28–35.
  • Flory JD, Yehuda R. Comorbidity between post-traumatic stress disorder and major depressive disorder: alternative explanations and treatment considerations. Dialogues Clin Neurosci. 2015;17:141–150.
  • Khaleel N, Roopa R, Smitha JS, et al. Electroconvulsive therapy attenuates dendritic arborization in the basolateral amygdala. J ECT. 2013;29:156–157.
  • Khaleel N, Ravindranath R, Sagar BK, et al. Images in electroconvulsive therapy: pilot impressions suggesting that ECT reduces excitatory synapses in the basolateral amygdala. Indian J Psychiatry. 2013;55:204–205.
  • Benarroch EE. The amygdala: functional organization and involvement in neurologic disorders. Neurology. 2015;84:313–324.
  • Andrade C. A primer for the conceptualization of the mechanism of action of electroconvulsive therapy, 1: defining the question. J Clin Psychiatry. 2014;75:e410–e412.
  • Andrade C. A primer for the conceptualization of the mechanism of action of electroconvulsive therapy, 2: organizing the information. J Clin Psychiatry. 2014;75:e548–e551.
  • Nagaraja N, Andrade C, Sudha S, et al. Glucocorticoid mechanisms may contribute to ECT-induced retrograde amnesia. Psychopharmacology [Berl]. 2007;190:73–80.
  • Andrade C. Molecular mechanisms underlying electroconvulsive therapy-induced amnestic deficits: a decade of research. Indian J Psychiatry. 2008;50:244–252.
  • Andrade C, Singh NM, Thyagarajan S, et al. Possible glutamatergic and lipid signalling mechanisms in ECT-induced retrograde amnesia: experimental evidence for involvement of COX-2, and review of literature. J Psychiatr Res. 2008;42:837–850.
  • Andrade C, Thyagarajan S, Singh NM, et al. Celecoxib as an in vivo probe of cyclooxygenase-2 mechanisms underlying retrograde amnesia in an animal model of ECT. J Neural Transm [Vienna]. 2008;115:1063–1070.
  • Andrade C, Shaikh SA, Narayan L, et al. Administration of a selective glucocorticoid antagonist attenuates electroconvulsive shock-induced retrograde amnesia. J Neural Transm [Vienna]. 2012;119:337–344.
  • Joshi SH, Espinoza RT, Pirnia T, et al. Structural plasticity of the hippocampus and amygdala induced by electroconvulsive therapy in major depression. Biol Psychiatry. 2016;79:282–292.
  • Andrade C, Rao NS. How antidepressant drugs act: A primer on neuroplasticity as the eventual mediator of antidepressant efficacy. Indian J Psychiatry. 2010;52:378–386.
  • Smitha JS, Roopa R, Khaleel N, et al. Images in electroconvulsive therapy: electroconvulsive shocks dose-dependently increase dendritic arborization in the CA1 region of the rat hippocampus. J ECT. 2014;30:191–192.
  • Smitha JS, Roopa R, Sagar BK, et al. Images in electroconvulsive therapy: ECS dose-dependently increases cell proliferation in the subgranular region of the rat hippocampus. J ECT. 2014;30:193–194.
  • Gombos Z, Spiller A, Cottrell GA, et al. Mossy fiber sprouting induced by repeated electroconvulsive shock seizures. Brain Res. 1999;844:28–33.
  • Lamont SR, Paulls A, Stewart CA. Repeated electroconvulsive stimulation, but not antidepressant drugs, induces mossy fibre sprouting in the rat hippocampus. Brain Res. 2001;893:53–58.
  • Akers KG, Martinez-Canabal A, Restivo L, et al. Hippocampal neurogenesis regulates forgetting during adulthood and infancy. Science. 2014;344:598–602.
  • de Beukelaar TT, Woolley DG, Wenderoth N. Gone for 60 seconds: reactivation length determines motor memory degradation during reconsolidation. Cortex. 2014;59:138–145.
  • Bjorkstrand J, Agren T, Frick A, et al. Disruption of memory reconsolidation erases a fear memory trace in the human amygdala: an 18-month follow-up. PLoS One. 2015;10:e0129393.
  • Monfils MH, Cowansage KK, Klann E, et al. Extinction-reconsolidation boundaries: key to persistent attenuation of fear memories. Science. 2009;324:951–955.
  • Schiller D, Monfils M-H, Raio CM, et al. Preventing the return of fear in humans using reconsolidation update mechanisms. Nature. 2010;463:49–53.
  • Kroes MCW, Tendolkar I, van Wingen GA, et al. An electroconvulsive therapy procedure impairs reconsolidation of episodic memories in humans. Nat Neurosci. 2014;17:204–206.
  • Dekel S, Solomon Z. Ein-Dor T. PTSD symptoms lead to modification in the memory of the trauma: a prospective study of former prisoners of war. J Clin Psychiatry. 2016;77(3):e290–e296. doi:10.4088/JCP.14m09114.
  • Gahr M, Schonfeldt-Lecuona C, Spitzer M, et al. Electroconvulsive therapy and posttraumatic stress disorder: first experience with conversation-based reactivation of traumatic memory contents and subsequent ECT-mediated impairment of reconsolidation. J Neuropsychiatry Clin Neurosci. 2014;26:E38–E39.
  • Andrade C. Electroconvulsive therapy. In: Bhugra D, Ranjith G, Patel V, editors. Handbook of psychiatry: a South Asian perspective. New Delhi: Byword Publishers; 2005. p. 553–568.
  • Andrade C, Arumugham SS, Thirthalli J. Adverse effects of electroconvulsive therapy. Psychiatr Clin North Am. Forthcoming 2016.
  • Krystal J, Neumeister A. Noradrenergic and serotonergic mechanisms in the neurobiology of posttraumatic stress disorder and resilience. Brain Res. 2009;1293:13–23.
  • De Berardis D, Marini S, Serroni N, et al. Targeting the noradrenergic system in posttraumatic stress disorder: a systematic review and meta-analysis of prazosin trials. Curr Drug Targets. 2015;16:1094–1106.
  • Andrade C, Sudha S. Electroconvulsive therapy and the alpha-2 noradrenergic receptor: implications of treatment schedule effects. J ECT. 2000;16:268–278.
  • Lillethorup TP, Iversen P, Fontain J, et al. Electroconvulsive shocks decrease a2-adrenoceptor binding in the Flinders rat model of depression. Eur Neuropsychopharmacol. 2015;25:404–412.
  • Gangadhar BN, Ramadevi G, Andrade C, et al. Dopaminergic effects of repeated electroconvulsive shocks. Convuls Ther. 1989;5:157–161.
  • Andrade C, Srinivasamurthy GM, Vishwasenani A, et al. High but not low ECS stimulus intensity augments apomorphine-stimulated dopamine postsynaptic receptor functioning in rats. J ECT. 2002;18:80–83.
  • Baldinger P, Lotan A, Frey R, et al. Neurotransmitters and electroconvulsive therapy. J ECT. 2014;30:116–121.
  • Cumper SK, Ahle GM, Liebman LS, et al. Electroconvulsive therapy [ECT] in Parkinson’s disease: ECS and dopamine enhancement. J ECT. 2014;30:122–124.
  • Rosenquist PB, Miller B, Pillai A. The antipsychotic effects of ECT: a review of possible mechanisms. J ECT. 2014;30:125–131.
  • Pillar G, Malhotra A, Lavie P. Post-traumatic stress disorder and sleep-what a nightmare! Sleep Med Rev. 2000;4:183–200.
  • McCall W, Rosenquist P. The effect of ECT on sleep - a comment to Winkler et al. J Psychiatr Res. 2015;61:239–240.
  • Wood NE, Rosasco ML, Suris AM, et al. Pharmacological blockade of memory reconsolidation in posttraumatic stress disorder: three negative psychophysiological studies. Psychiatry Res. 2015;225:31–39.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.